Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-006995

See Remarks acquired 157,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sinha Vikas See Remarks 2023-02-02 Grant or award +157,500 1,187,738 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sinha Vikas See Remarks 2023-02-02 Grant or award · Stock Option (Right to Buy) +292,500 1,012,362 D: show line 2 in the form
Loading xslF345X03/doc4.xml…